VC005 tablets: Clinical Trials

8 trials of VC005 tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 not yet recruiting, 1 recruiting. 8 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 6, Not yet recruiting 1, Recruiting 1
Phase 21Not yet recruiting 1

Follow VC005 tablets: new trials by email Literature Review of VC005 tablets trials Research Report on VC005 tablets

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo
VC005 tablets - Non-Segmental Vitiligo
Phase 1 / Phase 2Not yet recruitingJiangsu vcare pharmaceutical technology co., LTD102026-09-252026-09-18
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata
VC005 tablets - Alopecia Areata
Phase 1RecruitingJiangsu vcare pharmaceutical technology co., LTD242026-09-222026-10-20
Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function
VC005 Tablets - Renal Impairment
Phase 1CompletedJiangsu vcare pharmaceutical technology co., LTD322026-05-092026-08-20
Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function
VC005 Tablets - Hepatic Impairment and Healthy Female
Phase 1CompletedJiangsu vcare pharmaceutical technology co., LTD242026-04-292026-08-20
A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.
VC005 Tablets - Atopic Dermatitis
Phase 1CompletedJiangsu vcare pharmaceutical technology co., LTD312026-04-232026-06-08
A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.
VC005 tablets, VC005 Tablets Placebo - Rheumatoid Arthritis
Phase 1CompletedJiangsu vcare pharmaceutical technology co., LTD302023-06-122023-11-03
Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects
VC005 tablets, VC005 Placebo tablets - Inflammatory Bowel Diseases
Phase 1CompletedJiangsu vcare pharmaceutical technology co., LTD602022-06-182022-11-17
Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects
VC005 Tablets, VC005 Tablets Placebo, VC005 Tablets food effects group - Inflammatory Bowel Diseases
Phase 1CompletedJiangsu vcare pharmaceutical technology co., LTD782021-11-182022-09-02

Conditions studied

Inflammatory Bowel Diseases (2)  ·  Alopecia Areata (1)  ·  Arthritis, Rheumatoid (1)  ·  Dermatitis, Atopic (1)  ·  Renal Insufficiency (1)

Sponsors

Jiangsu vcare pharmaceutical technology co., LTD (8)

Countries

China (8)

Top investigators

Huan Zhou (2)  ·  Jianzhong Zhang (1)  ·  Jianzhong Zhang Zhang (1)  ·  Nanya Wang (1)  ·  Yanhua Ding (1)